Trevi Therapeutics, Inc. (TRVI)

Trevi Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	56.87	34.1	32.4	12.59	36.83	45
Short-Term Investments	138.06	73.53	50.57	107.92	-	-
Cash & Short-Term Investments	194.93	107.62	82.97	120.51	36.83	45
Cash Growth	197.63%	29.71%	-31.15%	227.21%	-18.16%	-21.48%
Other Receivables	1.2	0.53	0.49	-	-	-
Receivables	1.2	0.53	0.49	-	-	-
Prepaid Expenses	1.38	0.94	3.62	0.8	0.89	1
Other Current Assets	0.79	0.34	0.47	1.31	0.24	0.27
Total Current Assets	198.3	109.43	87.55	122.62	37.96	46.27
Property, Plant & Equipment	0.95	1.23	1.56	0.19	0.18	0.33
Other Long-Term Assets	0.1	0.24	0.3	0.21	0.33	0.53
Total Assets	199.36	110.9	89.4	123.02	38.48	47.13
Accounts Payable	2.71	3.41	1.81	2.86	2.85	2.02
Accrued Expenses	6.04	6.81	3.71	3.52	3.81	3.43
Current Portion of Long-Term Debt	-	-	-	7	5.95	-
Current Portion of Leases	0.3	0.29	0.31	0.03	0.12	0.11
Total Current Liabilities	9.04	10.51	5.82	13.4	12.72	5.56
Long-Term Debt	-	-	-	2.15	8.65	13.95
Long-Term Leases	0.53	0.75	1.03	0	0.02	0.14
Other Long-Term Liabilities	-	-	-	0	-	0.2
Total Liabilities	9.57	11.26	6.86	15.56	21.4	19.85
Common Stock	0.13	0.09	0.07	0.06	0.03	0.02
Additional Paid-In Capital	511.12	386.53	321.64	317.59	197.96	174.24
Retained Earnings	-321.49	-287.05	-239.13	-210.07	-180.92	-146.98
Comprehensive Income & Other	0.03	0.06	-0.03	-0.12	-	-
Total Common Equity	189.79	99.64	82.55	107.46	17.08	27.28
Shareholders' Equity	189.79	99.64	82.55	107.46	17.08	27.28
Total Liabilities & Equity	199.36	110.9	89.4	123.02	38.48	47.13
Total Debt	0.82	1.03	1.34	9.18	14.74	14.21
Net Cash (Debt)	194.1	106.59	81.63	111.33	22.09	30.79
Net Cash Growth	201.50%	30.57%	-26.68%	404.06%	-28.27%	-45.94%
Net Cash Per Share	1.55	1.05	0.82	1.72	0.97	1.70
Filing Date Shares Outstanding	128.23	96.68	68.96	60.05	30.81	19.91
Total Common Shares Outstanding	128.22	93.6	68.28	59.94	28.51	18.55
Working Capital	189.26	98.92	81.72	109.22	25.23	40.71
Book Value Per Share	1.48	1.06	1.21	1.79	0.60	1.47
Tangible Book Value	189.79	99.64	82.55	107.46	17.08	27.28
Tangible Book Value Per Share	1.48	1.06	1.21	1.79	0.60	1.47
Machinery	-	0.35	0.3	0.21	0.11	0.11
Construction In Progress	-	0.01	0.02	0.05	-	-
Leasehold Improvements	-	0.03	0.03	0.13	0.13	0.13

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q